Skip to main navigation Skip to search Skip to main content

Design, synthesis, and biological evaluation of β-ketosulfonamide adenylation inhibitors as potential antitubercular agents

  • Jagadeshwar Vannada
  • , Eric M. Bennett
  • , Daniel J. Wilson
  • , Helena I. Boshoff
  • , Clifton E. Barry
  • , Courtney C. Aldrich

Research output: Contribution to journalArticlepeer-review

Abstract

(Chemical Equation Presented) The antitubercular nucleoside antibiotics 1 and 2 were recently described that inhibit the adenylate-forming enzyme MbtA and disrupt biosynthesis of the virulence-conferring siderophore known as mycobactin in Mycobacterium tuberculosis. Herein, we report efforts to refine this inhibitor scaffold by replacing the labile acylsulfamate linkage (highlighted) with the more chemically robust β-ketosulfonamide linkage of 3 and 4.

Original languageEnglish (US)
Pages (from-to)4707-4710
Number of pages4
JournalOrganic Letters
Volume8
Issue number21
DOIs
StatePublished - Oct 12 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Design, synthesis, and biological evaluation of β-ketosulfonamide adenylation inhibitors as potential antitubercular agents'. Together they form a unique fingerprint.

Cite this